UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)

TH open : companion journal to thrombosis and haemostasis, 2022-01, Vol.6 (1), p.e60-e69

2022

Volltextzugriff (PDF)

Alternative drug formulations of docetaxel: a review

Anti-cancer drugs, 2007-02, Vol.18 (2), p.95-103

2007

Volltextzugriff (PDF)

Correlation between trough concentration and AUC for elexacaftor, tezacaftor and ivacaftor

Journal of cystic fibrosis, 2024-03

2024

Volltextzugriff (PDF)

Paracetamol clinical dosing routine leads to paracetamol underexposure in an adult severely ill sub-Saharan African hospital population: a drug concentration measurement study

BMC research notes, 2017-12, Vol.10 (1), p.671-671, Article 671

2017

Volltextzugriff (PDF)

Perioperative FVIII Concentrate Treatment in Mild Hemophilia a Patients Shows a High Rate of Overdosing - David/Opti-Clot Studies

Blood, 2015-12, Vol.126 (23), p.3510-3510

2015

Volltextzugriff (PDF)

Targeting Clotting Factor VIII Plasma Values in the Perioperative Setting in Hemophilia a: “Tackling a Moving Target” (“OPTI-CLOT” Studies)

Blood, 2014-12, Vol.124 (21), p.5031-5031

2014

Volltextzugriff (PDF)

Population Pharmacokinetics of Erwinia Asparaginase in Pediatric ALL Patients

Blood, 2015-12, Vol.126 (23), p.1281-1281

2015

Volltextzugriff (PDF)

Correction to: Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients

Pharmaceutical research, 2020-11, Vol.37 (11), p.223-223, Article 223

2020

Volltextzugriff (PDF)

Efficacy and safety of FOLFIRINOX in advanced biliary tract cancer after failure of gemcitabine plus cisplatin: A phase II trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4086-4086

2019

Volltextzugriff (PDF)

Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing : Characterization of tolerance

Clinical pharmacology and therapeutics, 1999-08, Vol.66 (2), p.140-151

1999

Volltextzugriff (PDF)

Sample collection, biobanking, and analysis

Handbook of experimental pharmacology, 2011, Vol.205, p.203

2011

Volltextzugriff (PDF)

Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab

mAbs, 2020, Vol.12 (1)

2020

Volltextzugriff (PDF)

Partial agonism of the nonselective adenosine receptor agonist 8-butylaminoadenosine at the A1 receptor in vivo

The Journal of pharmacology and experimental therapeutics, 1996-12, Vol.279 (3), p.1439

1996

Volltextzugriff (PDF)

8-Substituted adenosine and theophylline-7-riboside analogues as potential partial agonists for the adenosine A1 receptor

European journal of pharmacology. Molecular pharmacology section, 1995-08, Vol.290 (3), p.189-199

1995

Volltextzugriff (PDF)

8-substituted adenosine and theophylline-7-riboside analogues as potential partial agonists for the adenosine A 1 receptor

European journal of pharmacology. Molecular pharmacology section, 1995, Vol.290 (3), p.189-199

1995

Volltextzugriff (PDF)

Irinotecan chemotherapy during valproic acid treatment: Pharmacokinetic interaction and hepatotoxicity

Cancer Biology & Therapy, 2007, Vol.6 (9), p.1364-1370

2007

Volltextzugriff (PDF)

Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine

The Journal of pharmacology and experimental therapeutics, 1995-10, Vol.275 (1), p.245

1995

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)
Berichte
(2)

Sprache

Englisch
(20)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)

Alternative drug formulations of docetaxel: a review

Correlation between trough concentration and AUC for elexacaftor, tezacaftor and ivacaftor

Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study

Paracetamol clinical dosing routine leads to paracetamol underexposure in an adult severely ill sub-Saharan African hospital population: a drug concentration measurement study

Perioperative FVIII Concentrate Treatment in Mild Hemophilia a Patients Shows a High Rate of Overdosing - David/Opti-Clot Studies

Targeting Clotting Factor VIII Plasma Values in the Perioperative Setting in Hemophilia a: “Tackling a Moving Target” (“OPTI-CLOT” Studies)

Population Pharmacokinetics of Erwinia Asparaginase in Pediatric ALL Patients

Phase II Study on Bortezomib (BTZ) in Multiple Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (rALL): High Response Rate with a Modestly Intensive Regimen Including BTZ, Not Related to Pharmacokinetics

Correction to: Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients

Efficacy and safety of FOLFIRINOX in advanced biliary tract cancer after failure of gemcitabine plus cisplatin: A phase II trial

Feasibility study of trastuzumab (T) and pertuzumab (P) added to neoadjuvant chemoradiotherapy (nCRT) in resectable HER2+ esophageal adenocarcinoma (EAC) patients (pts): The TRAP study

Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing : Characterization of tolerance

Sample collection, biobanking, and analysis

Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab

Partial agonism of the nonselective adenosine receptor agonist 8-butylaminoadenosine at the A1 receptor in vivo

8-Substituted adenosine and theophylline-7-riboside analogues as potential partial agonists for the adenosine A1 receptor

8-substituted adenosine and theophylline-7-riboside analogues as potential partial agonists for the adenosine A 1 receptor

Irinotecan chemotherapy during valproic acid treatment: Pharmacokinetic interaction and hepatotoxicity

Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine

Aktive Filter

Suchergebnisse filtern